Scans and blood tests to predict memory changes after brain radiation
Original title: MRI in High-Grade Glioma Patients Undergoing Chemoradiation
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This study lists no phase, so we treat it as an early study in people.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study checks if scans and blood tests can predict memory changes after radiation.
Who this trial is for. This trial is for people with high-grade glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary who get radiation along with chemotherapy. It tests if PET scans, blood tests, and an optional spinal tap can predict thinking changes.
Where it stands. This trial has not reported results. It is measuring changes in memory and attention after radiation. The answer is not in yet.
What this means, and what it doesn't
What it could mean: Most people have at least mild drops in memory or attention after radiation. This study may help doctors learn who is likely to have bigger changes. Someone who fits could ask their care team about it.
What it doesn't mean: A trial is a test, not proven care. Joining one is not a promise that it will help you. It is not a cure. This study does not offer treatment known to protect memory.
Source: ClinicalTrials.gov, August 17, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.